🕷️ Crawler Inspector

All Sections Search [ Read The Diplomat, Know The Asia-Pacific](https://thediplomat.com/) | | | | | | | | | | | | | | | | | |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| | [Central Asia](https://thediplomat.com/regions/central-asia/) | [East Asia](https://thediplomat.com/regions/east-asia/) | [Oceania](https://thediplomat.com/regions/oceania-region/) | [South Asia](https://thediplomat.com/regions/south-asia/) | [Southeast Asia](https://thediplomat.com/regions/southeast-asia/) | \| | [Security](https://thediplomat.com/topics/security/) | [Politics](https://thediplomat.com/topics/politics/) | [Diplomacy](https://thediplomat.com/topics/diplomacy/) | [Economy](https://thediplomat.com/topics/economy/) | [Society](https://thediplomat.com/topics/society/) | [Environment](https://thediplomat.com/topics/environment/) | [Opinion](https://thediplomat.com/topics/opinion/) | [Features](https://thediplomat.com/category/features/) | \| | All | Regions - [Central Asia](https://thediplomat.com/regions/central-asia/) - [East Asia](https://thediplomat.com/regions/east-asia/) - [Oceania](https://thediplomat.com/regions/oceania-region/) - [South Asia](https://thediplomat.com/regions/south-asia/) - [Southeast Asia](https://thediplomat.com/regions/southeast-asia/) Topics - [Diplomacy](https://thediplomat.com/topics/diplomacy/) - [Economy](https://thediplomat.com/topics/economy/) - [Environment](https://thediplomat.com/topics/environment/) - [Opinion](https://thediplomat.com/topics/opinion/) - [Politics](https://thediplomat.com/topics/politics/) - [Security](https://thediplomat.com/topics/security/) - [Society](https://thediplomat.com/topics/society/) Blogs - [ASEAN Beat](https://thediplomat.com/category/asean-beat/) - [Asia Defense](https://thediplomat.com/category/asia-defense/) - [China Power](https://thediplomat.com/category/china-power/) - [Crossroads Asia](https://thediplomat.com/category/crossroads-asia/) - [Flashpoints](https://thediplomat.com/category/flashpoints/) - [Oceania](https://thediplomat.com/category/oceania/) - [Pacific Money](https://thediplomat.com/category/pacific-money/) - [The Debate](https://thediplomat.com/category/the-debate/) - [The Koreas](https://thediplomat.com/category/the-koreas/) - [The Pulse](https://thediplomat.com/category/the-pulse/) - [Tokyo Report](https://thediplomat.com/category/tokyo-report/) - [Trans-Pacific View](https://thediplomat.com/category/trans-pacific-view/) More - [Features](https://thediplomat.com/category/features/) - [Interviews](https://thediplomat.com/category/interviews/) - [Photo Essays](https://thediplomat.com/category/photo-essays/) - [Podcasts](https://thediplomat.com/category/podcasts/) - [Videos](https://thediplomat.com/category/videos/) Newsletter [**Diplomat Brief** Weekly Newsletter](https://thediplomat.com/newsletter/) The Diplomat - [Home Page](https://thediplomat.com/) - [About Us](https://thediplomat.com/the-diplomat/) - [Contact Us](https://thediplomat.com/contact-us/) - [Write for Us](https://thediplomat.com/write-for-us/) - [Advertise](https://thediplomat.com/about-us/advertise/) - [Syndicate](https://thediplomat.com/syndication/) - [Privacy](https://thediplomat.com/privacy-policy/) - [Newsletter](https://thediplomat.com/newsletter/) - [Subscriptions](https://thediplomat.com/subscriptions/) ##### Pacific Money #### Why Malaysia’s Pharmaniaga Is In Financial Trouble ### Recent Features [SocietyForgotten Faces in the Contested South China Sea](https://thediplomat.com/2026/04/forgotten-faces-in-the-contested-south-china-sea/) [DiplomacyWhen Trump Goes to China: It’s the Strategy That Matters](https://thediplomat.com/2026/04/when-trump-goes-to-china-its-the-strategy-that-matters/) [SecurityChina, the Philippines, and the Real Lesson of Second Thomas Shoal](https://thediplomat.com/2026/04/china-the-philippines-and-the-real-lesson-of-second-thomas-shoal/) [SocietyThe Rise of Chinese Organized Crime in Chile](https://thediplomat.com/2026/03/the-rise-of-chinese-organized-crime-in-chile/) [VideosIs South Korea About to Finally Get Full Control of Its Own Military?](https://thediplomat.com/2026/03/is-south-korea-about-to-finally-get-full-control-of-its-own-military/) [SecurityWhat the West Misses About China’s Nuclear Build-up](https://thediplomat.com/2026/03/what-the-west-misses-about-chinas-nuclear-build-up/) [EnvironmentHow an Indonesian Pulp Giant Built a Carbon Project to Save a Forest From Itself](https://thediplomat.com/2026/03/how-an-indonesian-pulp-giant-built-a-carbon-project-to-save-a-forest-from-itself/) [DiplomacyHow the Iran War Will Reconfigure Militancy in Balochistan](https://thediplomat.com/2026/03/how-the-iran-war-will-reconfigure-militancy-in-balochistan/) [SecurityThe Private Firms Powering China’s Military AI Push](https://thediplomat.com/2026/03/the-private-firms-powering-chinas-military-ai-push/) [SocietyWhy Bangladeshi Villagers Are Worried About the Iran-US War](https://thediplomat.com/2026/03/why-bangladeshi-villagers-are-worried-about-the-iran-us-war/) [VideosWho Is Winning Southeast Asia’s Chip Race?](https://thediplomat.com/2026/03/who-is-winning-southeast-asias-chip-race/) [SecurityWere Foreign Nationals and Myanmar Rebel Groups Plotting an Attack Against India?](https://thediplomat.com/2026/03/were-foreign-nationals-and-myanmar-rebel-groups-plotting-an-attack-against-india/) ### [Pacific Money](https://thediplomat.com/category/pacific-money/) \| [Economy](https://thediplomat.com/topics/economy/) \| [Southeast Asia](https://thediplomat.com/regions/southeast-asia/) # Why Malaysia’s Pharmaniaga Is In Financial Trouble And why its troubles might be short-lived.  By [James Guild](https://thediplomat.com/authors/james-guild/) February 20, 2024  Credit: [Depositphotos](https://depositphotos.com/459247588/stock-photo-cropped-view-doctor-latex-gloves.htmlhttps://depositphotos.com/stock-photos/covid-19-vaccine.html?filter=all&qview=459247588) Pharmaniaga is one of the largest pharmaceutical distributors in Malaysia. A big part of its success is that since 1994 it has been awarded a government concession to provide medical supplies to the public sector. But Pharmaniaga is not a state-owned company, in that the government of Malaysia does not directly own shares. Instead, it is majority-owned by Boustead Holdings, a diversified conglomerate owned by a military pension fund (Lembaga Tabung Angkatan Tentera, or LTAT) which is, in turn, controlled by the government. This ownership structure, in which the state has indirect ownership in firms through various layers of holding and investment companies, is common in Malaysia. It also has interesting implications for how such companies are run and how they fit into the wider political economy. The majority of Pharmaniaga’s business comes from the state, with about 66 percent of revenue coming from government contracts in 2020. But lately, despite this closeness, the pharmaceutical company has fallen on hard times (for simplicity’s sake I have converted amounts from Malaysian ringgit to USD at the current exchange rate). In 2022, despite earning \$730 million in revenue, Pharmaniaga posted a net loss of \$126 million. This caused liabilities to exceed assets, which turned the company’s equity negative. The board of directors now has “significant doubt over the ability of the Group and the Company to continue as going concerns.” You might expect a big conglomerate like Boustead Holdings to be capable of carrying these losses for the short term. But the past few years have already been rough, with Boustead eating huge losses from another subsidiary on a [disastrous naval modernization](https://thediplomat.com/2023/10/why-the-malaysian-state-is-taking-firmer-control-over-boustead-holdings/) project. Pharmaniaga’s financial woes are only adding to that, and the main cause is simple enough: during the pandemic, it procured and stockpiled too many COVID-19 vaccines and was then unable to sell them. Because of this, the company was forced to take a write-down of about \$115 million. Initially, Pharmaniaga signed a contract with the Malaysian government to [provide 12 million doses](https://themalaysianreserve.com/2021/07/16/pharmaniaga-says-it-met-12-million-sinovac-doses-order/) of the Sinovac vaccine. The contract was structured in such a way that Pharmaniaga would receive the raw materials and then “fill and finish” the vaccines at its manufacturing facility in Malaysia before distributing them as part of the national vaccination campaign. By mid-2021, all 12 million doses had been delivered. However, Pharmaniaga did not want to stop there. 2021 was a very profitable year, almost entirely due to this newfound role in the supply chain of Sinovac vaccines. Although Pharmaniaga has research and development, and production facilities, historically it has mostly been a distributor of medicine and medical supplies. But manufacturing is a much more profitable line of business. According to the [2022 Annual Report](https://pharmaniaga.com/investor-relations-2/reports/), the expected rate of profit from distribution and logistics is around 7 percent. For manufacturing, margins can rise as high as 32 percent. To capitalize on this and anticipating that demand would remain high during the pandemic, Pharmaniaga produced millions of additional vaccines in excess of the initial order. But demand was not as high as expected. To hedge its bets against supply bottlenecks, the Malaysian government ordered vaccines from [numerous manufacturers](https://asia.nikkei.com/Spotlight/Coronavirus/Malaysia-starts-COVID-vaccines-in-crucial-week-for-Asian-jabs), including Pfizer and AstraZeneca. Pfizer ended up being the main vaccine supplier, with over 40 million distributed. In an [interview with The Edge](https://theedgemalaysia.com/node/678728), former Health Minister Khairy Jamaluddin who was in charge of the national vaccination program, was adamant that he told Pharmaniaga he only needed the initial order of 12 million doses. Anything beyond that was their call, and at their own risk. Without this guaranteed demand from the government (which is, we should remember, how Pharmaniaga traditionally makes most of its money), the pharmaceutical firm was unable to offload its extra vaccines and eventually had to write off the entire unused inventory as a loss. With negative equity and lenders starting to call in their debts, Pharmaniaga has entered a compulsory restructuring process. And were it a regular private market firm, the future might be bleak. But Pharmaniaga has something that most companies don’t, and that is its special relationship with the government. After some delay, the Ministry of Health recently [extended the concession agreement](https://theedgemalaysia.com/node/696135) for a further seven years, which means Pharmaniaga will continue providing medical supplies to government hospitals and facilities until at least 2030. The value of the contract was not disclosed, but we know this concession brings in hundreds of millions of dollars annually in revenue. As the company works to shore up its balance sheet and return to profitability, having a customer like the government to fall back on is a major shot in the arm for those efforts. Authors  ##### Guest Author #### James Guild James Guild is an expert in trade, finance, and economic development in Southeast Asia. [View Profile](https://thediplomat.com/authors/james-guild/) Tags - [Pacific Money](https://thediplomat.com/category/pacific-money/) - [Economy](https://thediplomat.com/topics/economy/) - [Southeast Asia](https://thediplomat.com/regions/southeast-asia/) - [Malaysia](https://thediplomat.com/countries/malaysia/) - [Boustead Holdings](https://thediplomat.com/tag/boustead-holdings/) - [Malaysia economy](https://thediplomat.com/tag/malaysia-economy/) - [pharmaceuticals](https://thediplomat.com/tag/pharmaceuticals/) - [Pharmaniaga](https://thediplomat.com/tag/pharmaniaga/) ### [Latest Stories](https://thediplomat.com/category/blogs/) [Mongolia’s Schools Have a Violence Problem That Goes Far Deeper Than Viral Videos](https://thediplomat.com/2026/04/mongolias-schools-have-a-violence-problem-that-goes-far-deeper-than-viral-videos/) [Australia’s EU Critical Minerals Deal Is No Quick Fix for Its China Dependence](https://thediplomat.com/2026/04/australias-eu-critical-minerals-deal-is-no-quick-fix-for-its-china-dependence/) [Beijing Is Racing to Get Concessions From Taiwan’s KMT](https://thediplomat.com/2026/04/beijing-is-racing-to-get-concessions-from-taiwans-kmt/) [Why the Aral Sea’s Restoration Matters Beyond Central Asia](https://thediplomat.com/2026/04/why-the-aral-seas-restoration-matters-beyond-central-asia/) ### Diplomat Brief #### Weekly Newsletter Get briefed on the story of the week, and developing stories to watch across the Asia-Pacific. [Get the Newsletter](https://thediplomat.com/newsletter/) ### Related [Malaysia’s State-Run Investment Funds Had a Mixed 2023By James GuildThe performance of two major Malaysian funds demonstrates both the strength and weakness of forced savings policies.](https://thediplomat.com/2024/03/malaysias-state-run-investment-funds-had-a-mixed-2023/) [Breaking Down Malaysia’s 2026 BudgetBy James GuildThe budget contains few surprises, putting the country in a good position to face the uncertainty of the current global economic climate.](https://thediplomat.com/2025/10/breaking-down-malaysias-2026-budget/) [Why the National Energy Transition Roadmap Makes Sense for MalaysiaBy James GuildAs in other areas of the country's energy sector, the state is playing a leading role in developing renewable energy projects.](https://thediplomat.com/2025/06/why-the-national-energy-transition-roadmap-makes-sense-for-malaysia/) [Why Malaysia Airports Holdings Berhad Is Going PrivateBy James GuildWhen is privatization not really privatization?](https://thediplomat.com/2025/02/why-malaysia-airports-holdings-berhad-is-going-private/) ### Most Read [Is South Korea About to Finally Get Full Control of Its Own Military?OPCON transition would have major implications not just for the Korean Peninsula, but for the broader geopolitical struggle in the Indo-Pacific.](https://thediplomat.com/2026/03/is-south-korea-about-to-finally-get-full-control-of-its-own-military/) [Has the Iran War Revealed a Shift in India’s Grand Strategy?By Sandeep BhardwajWhatever happened to India’s promotion of a multipolar world?](https://thediplomat.com/2026/03/has-the-iran-war-revealed-a-shift-in-indias-grand-strategy/) [How an Indonesian Pulp Giant Built a Carbon Project to Save a Forest From ItselfBy Adi RenaldiA months-long investigation into APRIL Group’s flagship Riau Ecosytem Restoration reveals how its carbon project was built on a hypothetical deforestation threat that is unlikely to materialize.](https://thediplomat.com/2026/03/how-an-indonesian-pulp-giant-built-a-carbon-project-to-save-a-forest-from-itself/) [Indian Government Cracks Down on Video Reels Lampooning PM ModiBy Kavita ChowdhuryAuthorities took down a video that mocked Prime Minister Narendra Modi’s undignified behavior while meeting foreign leaders.](https://thediplomat.com/2026/03/indian-government-cracks-down-on-video-reels-lampooning-pm-modi/) ### [Features](https://thediplomat.com/category/features/) [Forgotten Faces in the Contested South China SeaBy Christelle NguyenVietnamese fishers, especially those who have faced physical violence from Chinese forces, suffer in silence.](https://thediplomat.com/2026/04/forgotten-faces-in-the-contested-south-china-sea/) [When Trump Goes to China: It’s the Strategy That MattersBy Patrick M. Cronin and Pinshan LaiThe Trump-Xi summit itself is likely to be less important than the divergent strategies that it may reveal.](https://thediplomat.com/2026/04/when-trump-goes-to-china-its-the-strategy-that-matters/) [China, the Philippines, and the Real Lesson of Second Thomas ShoalBy Jesse M. PascasioThe Provisional Understanding emerged because coercion failed to accomplish Chinese objectives at acceptable costs to Beijing.](https://thediplomat.com/2026/04/china-the-philippines-and-the-real-lesson-of-second-thomas-shoal/) [The Rise of Chinese Organized Crime in ChileBy Antonio CastilloChina-linked criminal networks employ legal businesses to conceal illicit activities ranging from human trafficking to scam and drug operations.](https://thediplomat.com/2026/03/the-rise-of-chinese-organized-crime-in-chile/) ### [Latest Stories](https://thediplomat.com/category/blogs/) [Mongolia’s Schools Have a Violence Problem That Goes Far Deeper Than Viral VideosBy Enkhmend AriunsukhWhen victimized students were asked where they turned for help, 44.5 percent said they searched the internet, while only 2.9 percent went to a friend and fewer than 3 percent contacted the police.](https://thediplomat.com/2026/04/mongolias-schools-have-a-violence-problem-that-goes-far-deeper-than-viral-videos/) [Australia’s EU Critical Minerals Deal Is No Quick Fix for Its China DependenceBy Marina ZhangEurope can provide capital, technology and market access, but it cannot quickly replace China’s unmatched role as a buyer, processor and integrated industrial ecosystem.](https://thediplomat.com/2026/04/australias-eu-critical-minerals-deal-is-no-quick-fix-for-its-china-dependence/) [Beijing Is Racing to Get Concessions From Taiwan’s KMTBy Seamus BoyleCheng Li-wun is the party’s most pro-Beijing chair in a decade – and China is rushing to take advantage.](https://thediplomat.com/2026/04/beijing-is-racing-to-get-concessions-from-taiwans-kmt/) [Why the Aral Sea’s Restoration Matters Beyond Central AsiaBy Askhat OrazbayThe Aral Sea’s story demonstrates how human actions can profoundly alter natural systems, yet it also shows that determined cooperation can begin to repair environmental damage that once seemed irreversible.](https://thediplomat.com/2026/04/why-the-aral-seas-restoration-matters-beyond-central-asia/) Regions - [Central Asia](https://thediplomat.com/regions/central-asia/) - [East Asia](https://thediplomat.com/regions/east-asia/) - [Oceania](https://thediplomat.com/regions/oceania-region/) - [South Asia](https://thediplomat.com/regions/south-asia/) - [Southeast Asia](https://thediplomat.com/regions/southeast-asia/) Topics - [Diplomacy](https://thediplomat.com/topics/diplomacy/) - [Economy](https://thediplomat.com/topics/economy/) - [Environment](https://thediplomat.com/topics/environment/) - [Opinion](https://thediplomat.com/topics/opinion/) - [Politics](https://thediplomat.com/topics/politics/) - [Security](https://thediplomat.com/topics/security/) - [Society](https://thediplomat.com/topics/society/) Blogs - [ASEAN Beat](https://thediplomat.com/category/asean-beat/) - [Asia Defense](https://thediplomat.com/category/asia-defense/) - [China Power](https://thediplomat.com/category/china-power/) - [Crossroads Asia](https://thediplomat.com/category/crossroads-asia/) - [Flashpoints](https://thediplomat.com/category/flashpoints/) - [Oceania](https://thediplomat.com/category/oceania/) - [Pacific Money](https://thediplomat.com/category/pacific-money/) - [The Debate](https://thediplomat.com/category/the-debate/) - [The Koreas](https://thediplomat.com/category/the-koreas/) - [The Pulse](https://thediplomat.com/category/the-pulse/) - [Tokyo Report](https://thediplomat.com/category/tokyo-report/) - [Trans-Pacific View](https://thediplomat.com/category/trans-pacific-view/) More - [Features](https://thediplomat.com/category/features/) - [Interviews](https://thediplomat.com/category/interviews/) - [Photo Essays](https://thediplomat.com/category/photo-essays/) - [Podcasts](https://thediplomat.com/category/podcasts/) - [Videos](https://thediplomat.com/category/videos/) Archives - [Magazine](https://magazine.thediplomat.com/) - [A New Japan](https://thediplomat.com/category/a-new-japan/) - [By Other Means](https://thediplomat.com/category/by-other-means/) - [APAC Insider](https://thediplomat.com/category/apac-insider/) - [Asia Life](https://thediplomat.com/category/asia-life/) - [Asia Scope](https://thediplomat.com/category/asia-scope/) - [China, What's Next?](https://thediplomat.com/category/whats-next-china/) - [Indian Decade](https://thediplomat.com/category/indian-decade/) - [James Holmes](https://thediplomat.com/category/james-holmes/) - [New Emissary](https://thediplomat.com/category/new-emissary/) - [New Leaders Forum](https://thediplomat.com/category/new-leaders-forum/) - [Sport & Culture](https://thediplomat.com/category/sport-culture/) - [Tech Biz](https://thediplomat.com/category/tech-biz/) - [Tokyo Notes](https://thediplomat.com/category/tokyo-notes/) - [Zachary Keck](https://thediplomat.com/category/zachary-keck/) The Diplomat - [About Us](https://thediplomat.com/the-diplomat/) - [Contact Us](https://thediplomat.com/contact-us/) - [Write for Us](https://thediplomat.com/write-for-us/) - [Advertise](https://thediplomat.com/about-us/advertise/) - [Syndicate](https://thediplomat.com/syndication/) - [Terms of Use](https://thediplomat.com/terms-of-use/) - [Privacy Policy](https://thediplomat.com/privacy-policy/) - [Newsletters](https://thediplomat.com/newsletter/) - [Subscriptions](https://thediplomat.com/subscriptions/) Newsletter [**Diplomat Brief** Weekly Newsletter](https://thediplomat.com/newsletter/) © 2026 Diplomat Media Inc. All Rights Reserved.

### [Pacific Money](https://thediplomat.com/category/pacific-money/) \| [Economy](https://thediplomat.com/topics/economy/) \| [Southeast Asia](https://thediplomat.com/regions/southeast-asia/) And why its troubles might be short-lived.  Credit: [Depositphotos](https://depositphotos.com/459247588/stock-photo-cropped-view-doctor-latex-gloves.htmlhttps://depositphotos.com/stock-photos/covid-19-vaccine.html?filter=all&qview=459247588) Pharmaniaga is one of the largest pharmaceutical distributors in Malaysia. A big part of its success is that since 1994 it has been awarded a government concession to provide medical supplies to the public sector. But Pharmaniaga is not a state-owned company, in that the government of Malaysia does not directly own shares. Instead, it is majority-owned by Boustead Holdings, a diversified conglomerate owned by a military pension fund (Lembaga Tabung Angkatan Tentera, or LTAT) which is, in turn, controlled by the government. This ownership structure, in which the state has indirect ownership in firms through various layers of holding and investment companies, is common in Malaysia. It also has interesting implications for how such companies are run and how they fit into the wider political economy. The majority of Pharmaniaga’s business comes from the state, with about 66 percent of revenue coming from government contracts in 2020. But lately, despite this closeness, the pharmaceutical company has fallen on hard times (for simplicity’s sake I have converted amounts from Malaysian ringgit to USD at the current exchange rate). In 2022, despite earning \$730 million in revenue, Pharmaniaga posted a net loss of \$126 million. This caused liabilities to exceed assets, which turned the company’s equity negative. The board of directors now has “significant doubt over the ability of the Group and the Company to continue as going concerns.” You might expect a big conglomerate like Boustead Holdings to be capable of carrying these losses for the short term. But the past few years have already been rough, with Boustead eating huge losses from another subsidiary on a [disastrous naval modernization](https://thediplomat.com/2023/10/why-the-malaysian-state-is-taking-firmer-control-over-boustead-holdings/) project. Pharmaniaga’s financial woes are only adding to that, and the main cause is simple enough: during the pandemic, it procured and stockpiled too many COVID-19 vaccines and was then unable to sell them. Because of this, the company was forced to take a write-down of about \$115 million. Initially, Pharmaniaga signed a contract with the Malaysian government to [provide 12 million doses](https://themalaysianreserve.com/2021/07/16/pharmaniaga-says-it-met-12-million-sinovac-doses-order/) of the Sinovac vaccine. The contract was structured in such a way that Pharmaniaga would receive the raw materials and then “fill and finish” the vaccines at its manufacturing facility in Malaysia before distributing them as part of the national vaccination campaign. By mid-2021, all 12 million doses had been delivered. However, Pharmaniaga did not want to stop there. 2021 was a very profitable year, almost entirely due to this newfound role in the supply chain of Sinovac vaccines. Although Pharmaniaga has research and development, and production facilities, historically it has mostly been a distributor of medicine and medical supplies. But manufacturing is a much more profitable line of business. According to the [2022 Annual Report](https://pharmaniaga.com/investor-relations-2/reports/), the expected rate of profit from distribution and logistics is around 7 percent. For manufacturing, margins can rise as high as 32 percent. To capitalize on this and anticipating that demand would remain high during the pandemic, Pharmaniaga produced millions of additional vaccines in excess of the initial order. But demand was not as high as expected. To hedge its bets against supply bottlenecks, the Malaysian government ordered vaccines from [numerous manufacturers](https://asia.nikkei.com/Spotlight/Coronavirus/Malaysia-starts-COVID-vaccines-in-crucial-week-for-Asian-jabs), including Pfizer and AstraZeneca. Pfizer ended up being the main vaccine supplier, with over 40 million distributed. In an [interview with The Edge](https://theedgemalaysia.com/node/678728), former Health Minister Khairy Jamaluddin who was in charge of the national vaccination program, was adamant that he told Pharmaniaga he only needed the initial order of 12 million doses. Anything beyond that was their call, and at their own risk. Without this guaranteed demand from the government (which is, we should remember, how Pharmaniaga traditionally makes most of its money), the pharmaceutical firm was unable to offload its extra vaccines and eventually had to write off the entire unused inventory as a loss. With negative equity and lenders starting to call in their debts, Pharmaniaga has entered a compulsory restructuring process. And were it a regular private market firm, the future might be bleak. But Pharmaniaga has something that most companies don’t, and that is its special relationship with the government. After some delay, the Ministry of Health recently [extended the concession agreement](https://theedgemalaysia.com/node/696135) for a further seven years, which means Pharmaniaga will continue providing medical supplies to government hospitals and facilities until at least 2030. The value of the contract was not disclosed, but we know this concession brings in hundreds of millions of dollars annually in revenue. As the company works to shore up its balance sheet and return to profitability, having a customer like the government to fall back on is a major shot in the arm for those efforts.